TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Time to progression (TTP) from MGUS to overt multiple myeloma
Endpoint domain: Mortality/survival
Primary endpoint: Changes in cognitive performances
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in EASI Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percent change in total body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Dendritic cell number and phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Dendritic cell function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Immune composition of the airway
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Attribution Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of new BCCs on the face
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Intracranial bleeding (including hemorrhagic stroke) and fatal bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Ventilator-free day at 28-day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pain Scale of Plantar Fasciitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foot Health Status Questioner Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Foot Function Index Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Objective Response Rate 2 (ORR2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normalization of 24h blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Perceptions of the patient-clinician relationship
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Appendicular skeletal muscle mass (ASM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-time sit-to-stand test (5TSTS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in WAIS-IV Coding Test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Grade 2 or higher radiation induced esophagitis
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Body Mass Index Z-Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Evaluation of sexual Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Evaluation of sexual function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amyloid PET Scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Tau PET Scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: HBV virological failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation with number of CD8 T-cell
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Hospital Anxiety and Depression scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Elasticity measured by elasto MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Viscosity measured by elasto MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of pCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to reach maximum plasma concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum IgG titre to Gamma-PN3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Composite outcome of cardiovascular mortality and CV events
Endpoint domain: Mortality/survival
Primary endpoint: Presence of Visibly Detectable Plaque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional activity and connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Sensor Glucose Value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 2-year nodal control rate
Endpoint domain: Mortality/survival
Primary endpoint: Sleep apnea syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients With Histology-confirmed Lesions Found by Hexvix Blue Light Cystoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of ECG adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of treatment-emergent systemic adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number and percentage of participants that have at least 1 treatment-emergent adverse event (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Duration of abstinence from tobacco use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intra-Interrater reliability of thoracic kyphosis measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total gestational weight gain (GWG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of total GWG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of women meeting the Institute of Medicine's GWG recommendation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in pain - Visual analog scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the Schiff Cold Air Sensitivity Scale (SCASS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Minutes of Daily Moderate-vigorous Physical Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Motivation and Pleasure Scale (MAP)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in responses to abuse-related questions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sensitivity of multi-target stool DNA test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of quantitative fecal immunochemical (FIT) test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foot Posture Index (FPI-6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of new HO lesions as assessed by CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of samplings
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Concordance of visual estimation and functional assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Fertility preservation success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Cefiderocol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cefiderocol clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cefiderocol maximum concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children's Anxiety Meter-State (CAM-S) assessment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in testicular volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Oxford knee score (OKS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in active knee range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of radiograph measurements on X-ray
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change on clinical impression of reduction quality on Computed tomography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of photophobia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of phonophobia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stool consistency and frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in quality of recovery
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Temporal parameters of EEG microstates C, D, E and F
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Inter-subject correlation index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time in Rapid Eye Movement(REM)-sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Subjects to Complete the ACT Program
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of oxygen desaturation episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of patients with at least 1 desaturation episode
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in the number of intraocular pressure lowering medications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with ≥20 percent intraocular pressure reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Strength Measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of gut engraftment of B. infantis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of gut engraftment of B. infantis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change from baseline in behavior problems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change from baseline in parenting
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean change from baseline in parenting (Impact scale)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: COPD Empowerment Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ipsilateral breast tumor recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: numbers of adverse events (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: proportion of patients with at least PASI 75 at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Incidence of adverse events following administration of BBP-671
Endpoint domain: Adverse events/effects
Primary endpoint: BBP-671 concentration dependent change in change from baseline in QTcF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Participants With at Least One Positively Adjudicated Acute Pancreatitis Episode
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in VAS pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients tolerating the transition to assisted breathing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of patients having an SBT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of patients being extubated within 48 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Accuracy in the remote associates task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity in distinguishing old versus newly presented visual stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alpha band power in EEG record
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Fitbit-assessed moderate-to-vigorous intensity physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Liver fibrosis prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver and biliary outcomes
Primary endpoint: Occurrence of segmental or global acute myocardial dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Symptom Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of nasopharyngeal hemorrhage
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative pharyngeal pain
Endpoint domain: Adverse events/effects
Primary endpoint: Positive conversion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in liver disease QOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Hospital readmissions and/or Emergency room (ER) visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Time in Range (70-180mg/dl)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time below Range (<54mg/dl and <70mg/dl)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time above Range (>180mg/dl and >250mg/dl)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Microbiome signature across the spectrum of asthma severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Association between asthma phenotype and microbiome signature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prediction of treatment response or resistance by microbiome signature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life (Physical Component Summary)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Progression-free survival (12 month PFS rate)
Endpoint domain: Mortality/survival
Primary endpoint: Diagnostic accuracy of AI-assisted fecal microbiome testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Total dose of norepinephrine utilized to maintain MAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of providers trained who continue to provide treatment for pre-cancer lesions of the cervix using thermal ablation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: HPV Clearance post treatment with TA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Pmean
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Social phobia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Panic disorder symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgical re-intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of Participants Achieving EASI 90
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Freezing of gait questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Knowledge Levels of Pediatric Oncology Nurses on Childhood Cancers and Care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient satisfaction of integrative intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Determine level of symptom interference in active treatment using the PRO-CTCAE
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Determine Patient QOL using Pediatric PROMIS
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pain Measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in indexed extracellular volume (iECV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects requiring mechanical ventilation or ECMO
Endpoint domain: Mortality/survival
Primary endpoint: Visceral adiposity (VAT) measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: RECIST 1.1 tumoral response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of Patients Who Complete the Study
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of Items Correctly Performed on the Investigator Designed Fidelity Checklist
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Penetration Aspiration Scale (PAS) ≥ 3 for solid placebo
Endpoint domain: Physiological/clinical
Endpoint subdomain: Swallowing outcomes
Primary endpoint: Penetration Aspiration Scale (PAS) ≥ 3 for crushed placebo
Endpoint domain: Physiological/clinical
Endpoint subdomain: Swallowing outcomes
Primary endpoint: Penetration Aspiration Scale (PAS) ≥ 3 for accompanying bolus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Swallowing outcomes
Primary endpoint: inter-brain synchronization (IBS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number/Rate of Words Learned
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Movement Disorders Society Unified Parkinson's Disease Rating Scale Part 3 (MDS-UPDRS III) off medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: amount of incontinence after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression to DME in the fellow eye
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving ASDAS LDA (< 2.1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of dose-limiting toxicity-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Model for End-Stage Liver Disease (MELD) score from baseline to 28th day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Exercise Cardiac Output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Tumour specificity of monoclonal antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Diagnostic performance of FujiLAM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Rate of undetectable measurable residual disease (uMRD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimum plasma concentrations of BIC, FTC, and TAF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum plasma concentrations of BIC, FTC, and TAF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve (AUC) plasma concentrations of BIC, FTC, and TAF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Breast conservation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of PLHIV with controlled blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: % of PLHIV with controlled blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pain interference scale (change from baseline)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pain severity scale (change from baseline)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number and Percentage of Participants with TEAEs Leading to Death
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Traumatic Grief Inventory Self Report Plus (TGI-SR+)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in headache burden
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Amygdala volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inspiratory Overlap
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Blood prostate specific antigen (PSA) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Appearance of repigmentation (AOR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total number of repigmentation non-segmental vitiligo (NSV) lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Extent area of repigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: alterations in complete spontaneous bowel movements per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change of performance status score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: The Child-Pugh score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intubation difficulty scale (IDS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cmax of ustekinumab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes